Eva Polverino

11.6k total citations · 1 hit paper
166 papers, 5.1k citations indexed

About

Eva Polverino is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Emergency Medical Services. According to data from OpenAlex, Eva Polverino has authored 166 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Pulmonary and Respiratory Medicine, 74 papers in Epidemiology and 33 papers in Emergency Medical Services. Recurrent topics in Eva Polverino's work include Cystic Fibrosis Research Advances (88 papers), Pneumonia and Respiratory Infections (50 papers) and Neonatal Respiratory Health Research (35 papers). Eva Polverino is often cited by papers focused on Cystic Fibrosis Research Advances (88 papers), Pneumonia and Respiratory Infections (50 papers) and Neonatal Respiratory Health Research (35 papers). Eva Polverino collaborates with scholars based in Spain, Italy and United Kingdom. Eva Polverino's co-authors include Catia Cillóniz, Rosario Menéndez, Antoní Torres, Albert Gabarrús, Miquel Ferrer, Josep Mensa, Antoni Torres, Santiago Ewig, Anthony De Soyza and Stefano Aliberti and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Eva Polverino

152 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory Response

2015 373 citations Antoní Torres, Oriol Sibila et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Polverino Spain	40	2.8k	2.6k	873	424	422	166	5.1k
Jordi Dorca Spain	44	1.6k 0.6×	3.5k 1.4×	1.1k 1.3×	606 1.4×	402 1.0×	143	5.5k
Adam T. Hill United Kingdom	44	4.8k 1.7×	3.4k 1.3×	899 1.0×	564 1.3×	704 1.7×	149	8.0k
Mark Woodhead United Kingdom	40	2.3k 0.8×	4.9k 1.9×	1.6k 1.8×	766 1.8×	441 1.0×	105	7.3k
Aran Singanayagam United Kingdom	36	1.4k 0.5×	1.9k 0.8×	643 0.7×	683 1.6×	429 1.0×	89	3.9k
Oriol Sibila Spain	32	2.1k 0.8×	1.3k 0.5×	491 0.6×	508 1.2×	453 1.1×	153	3.9k
Rosario Menéndez Spain	50	2.1k 0.7×	5.1k 2.0×	1.8k 2.0×	821 1.9×	270 0.6×	237	7.8k
Ronald F. Grossman Canada	33	2.0k 0.7×	2.1k 0.8×	695 0.8×	264 0.6×	1.0k 2.5×	77	4.7k
A. Bruce Montgomery United States	28	3.7k 1.3×	1.3k 0.5×	615 0.7×	188 0.4×	528 1.3×	55	4.6k
Frederic Manresa Spain	26	822 0.3×	2.4k 0.9×	702 0.8×	304 0.7×	324 0.8×	33	3.3k
J. González Spain	22	1.9k 0.7×	2.1k 0.8×	1.8k 2.1×	506 1.2×	266 0.6×	36	3.7k

Countries citing papers authored by Eva Polverino

Since Specialization

Citations

This map shows the geographic impact of Eva Polverino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Polverino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Polverino more than expected).

Fields of papers citing papers by Eva Polverino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Polverino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Polverino. The network helps show where Eva Polverino may publish in the future.

Co-authorship network of co-authors of Eva Polverino

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Polverino. A scholar is included among the top collaborators of Eva Polverino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Polverino. Eva Polverino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fernández‐Cancio, Mónica, Thomas Burgoyne, Rosario Carmona, et al.. (2024). Primary Ciliary Dyskinesia and Retinitis Pigmentosa: Novel RPGR Variant and Possible Modifier Gene. Cells. 13(6). 524–524. 1 indexed citations

Loebinger, Michael R., Stefano Aliberti, Charles Haworth, et al.. (2024). Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts. ERJ Open Research. 10(5). 791–2023. 1 indexed citations

Simonetta, Edoardo, et al.. (2024). Epidemiology of bronchiectasis. European Respiratory Review. 33(174). 240091–240091. 14 indexed citations

Carpagnano, Giovanna Elisiana, Vitaliano Nicola Quaranta, Claudia Crimi, et al.. (2023). Is Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from Eight Italian Centers. SHILAP Revista de lepidopterología. 3(4). 178–190. 1 indexed citations

Culebras, Mario, et al.. (2023). Serial lung ultrasound in monitoring viral pneumonia: the lesson learned from COVID-19. ERJ Open Research. 9(4). 17–2023. 1 indexed citations

Álvarez, Antonio, Paula Fernández‐Álvarez, Silvia Gärtner, et al.. (2021). Long-term Follow-up in Adult Patients with Cystic Fibrosis and Deep Intronic Splicing Variants. Archivos de Bronconeumología. 57(7). 501–503.

Herrero‐Cortina, Beatriz, Victoria Alcaraz-Serrano, Jordi Vilaró, Antoní Torres, & Eva Polverino. (2018). Impact of Hypertonic Saline Solutions on Sputum Expectoration and Their Safety Profile in Patients with Bronchiectasis: A Randomized Crossover Trial. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31(5). 281–289. 26 indexed citations

Torres, Antoní, Oriol Sibila, Miquel Ferrer, et al.. (2015). Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory Response. JAMA. 313(7). 677–677. 373 indexed citations breakdown →

Prina, Elena, Otávio T. Ranzani, Eva Polverino, et al.. (2014). Pseudomonas, enterobacteriaceae ESBL positive and staphylococcus MRSA: When to suspect them in CAP?. European Respiratory Journal. 44(Suppl 58). P2475–P2475. 1 indexed citations

10.

Moisés, Jorge, Joan R. Badia, Miquel Ferrer, et al.. (2014). Acute respiratory distress syndrome in patients admitted for community-acquired pneumonia. European Respiratory Journal. 44(Suppl 58). P4894–P4894. 1 indexed citations

11.

Herrero, Beatriz, et al.. (2014). Wet sputum as an objective outcome in a randomized crossover trial in NCF-BE: Reliability and responsiveness. European Respiratory Journal. 44(Suppl 58). P4274–P4274. 2 indexed citations

12.

Barker, Alan R., Anne O’Donnell, Philip J. Thompson, et al.. (2013). Two phase 3 placebo-controlled trials of aztreonam lysine for inhalation (AZLI) for non-cystic fibrosis bronchiectasis (NCFB). European Respiratory Journal. 42(Suppl 57). P4136–P4136. 10 indexed citations

13.

Polverino, Eva, Rosario Menéndez, Catia Cillóniz, et al.. (2013). Microbial aetiology and outcomes of CAP in bronchiectatic patients. European Respiratory Journal. 42(Suppl 57). 4646–4646. 1 indexed citations

14.

Sellarés, Jacobo, Alejandra López-Giraldo, Catia Cillóniz, et al.. (2013). Influence of Previous Use of Inhaled Corticoids on the Development of Pleural Effusion in Community-acquired Pneumonia. American Journal of Respiratory and Critical Care Medicine. 187(11). 1241–1248. 47 indexed citations

15.

Polverino, Eva, Antoni Torres, Rosario Menéndez, et al.. (2013). Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case–control study. Thorax. 68(11). 1007–1014. 57 indexed citations

16.

Cillóniz, Catia, Santiago Ewig, Eva Polverino, et al.. (2012). Community-acquired pneumonia in outpatients: aetiology and outcomes. European Respiratory Journal. 40(4). 931–938. 57 indexed citations

17.

Cillóniz, Catia, Santiago Ewig, Eva Polverino, et al.. (2011). Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes. Clinical Microbiology and Infection. 18(11). 1134–1142. 57 indexed citations

18.

Ferrer, Miquel, Antoní Torres, Soledad Reyes, et al.. (2011). Inhaled corticosteroids (ICS), systemic inflammatory response and mortality in community-acquired pneumonia (CAP). European Respiratory Journal. 38(Suppl 55). 4713–4713. 1 indexed citations

19.

Polverino, Eva, Catia Cillóniz, Valentina Balasso, et al.. (2010). Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax. 65(4). 354–359. 100 indexed citations

20.

Polverino, Eva, Federico P. Gómez, Néstor Soler, et al.. (2007). Gas Exchange Response to Short-Acting β2-Agonists in Chronic Obstructive Pulmonary Disease Severe Exacerbations. American Journal of Respiratory and Critical Care Medicine. 176(4). 350–355. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact